Table 3 Estimation results of Maximum-difference model. ^a

Severe stroke

7.85 (7.45–8.23)

6.81 (6.66–6.96)

7.13 (6.90–7.35)

6.58 (6.37–6.78)

Severe MI

6.73 (6.37–7.08)

5.86 (5.72–5.99)

6.06 (5.86–6.26)

5.73 (5.54–5.92)

Cancer

6.62 (6.26–6.97)

5.76 (5.63–5.90)

6.28 (6.07–6.48)

5.34 (5.16–5.52)

Moderate stroke

5.41 (5.08–5.75)

4.52 (4.39–4.65)

4.91 (4.72–5.10)

4.20 (4.03–4.37)

Moderate MI

4.46 (4.13–4.78)

3.69 (3.57–3.82)

4.05 (3.86–4.23)

3.41 (3.25–3.57)

Heart failure

4.11 (3.79–4.42)

3.28 (3.16–3.40)

3.51 (3.33–3.68)

3.11 (2.95–3.26)

Acute kidney failure

4.16 (3.84–4.48)

3.27 (3.15–3.39)

3.58 (3.40–3.76)

3.02 (2.86–3.18)

Type 2 diabetes

3.60 (3.28–3.92)

3.18 (3.06–3.30)

3.32 (3.13–3.50)

3.08 (2.92–3.25)

Liver injury

4.04 (3.72–4.36)

2.93 (2.81–3.05)

3.26 (3.08–3.44)

2.67 (2.51–2.82)

Unstable angina

2.42 (2.15–2.70)

1.94 (1.84–2.05)

2.08 (1.90–2.23)

1.84 (1.70–1.98)

Treatment discontinuation

0.90 (0.67–1.13)

0.80 (0.71–0.90)

.90 (0.76–1.04)

.72 (0.59–0.85)

Nausea/headache

0.67 (0.44–0.90)

0.36 (0.27–0.46)

.30 (0.16–0.44)

.42 (0.28–0.55)

Myopathy

Ref

Ref

Ref

Ref